Radient Technologies Inc. Provides Update on Filing of Quarterly Financial Statements and Provides Corporate Update
August 26 2020 - 4:00PM
Radient Technologies Inc. (“Radient” or the
“Company”) (
TSX Venture: RTI; OTCQX: RDDTF),
announces that the Company will be relying on the temporary 45 day
extension to the filing deadline of its interim financial
statements and management’s discussion and analysis (“MD&A”)
for the quarter ended June 30, 2020 granted by the Alberta
Securities Commission (“ASC”) in response to unprecedented
challenges resulting from COVID-19. The notice released states that
securities regulators will be providing coordinated relief
consisting of a 45-day extension for certain periodic filings
required to be made on or prior to August 31, 2020 as a result of
the COVID-19 pandemic.
As per National Instrument 51-102 Continuous
Disclosure Obligations, the Company was to file its quarterly
financial statements and MD&A by August 29, 2020. Relying on
ASC Blanket Order 51-519, which provides the Company with an
additional 45 days from the deadline to file, the Company expects
to file its quarterly financial statements and MD&A on or
before October 13, 2020. This will follow the fiscal year-end
results, which will be filed on or before September 14, 2020, as
previously disclosed.
The Company acknowledges that management and
other insiders are subject to an insider trading black-out policy,
that reflects the principles in section 9 of National Policy 11-207
Failure-to-File Cease Trade Orders and Revocations in Multiple
Jurisdictions, until the second trading day after the quarterly
filings have been disclosed.
Corporate update:
All material business developments since the
date of the Company’s filing of its interim financial statements
and MD&A for the period ended December 31, 2019 have been
disclosed.
About Radient
Radient Technologies is a commercial
manufacturer of high quality cannabinoid based formulations,
ingredients and products. Utilizing a proprietary extraction and
downstream processing platform that recovers up to 99% of
cannabinoids from the cannabis plant, Radient develops specialty
products and ingredients that contain a broad range of cannabinoid
and terpene profiles while meeting the highest standards of quality
and safety. Please visit www.radientinc.com for more
information.
SOURCE: Radient Technologies Inc.
For further information please contact:
Radient - Investor Relations, ir@radientinc.com
Forward Looking Information:
This press release contains “forward-looking
information” within the meaning of applicable Canadian securities
legislation. Forward-looking information includes, without
limitation, statements regarding the growth of the Company’s
business operations; the Company’s ability to grow its business in
the cannabis sector, the filing of the Company’s financial
statements and corresponding MD&A and the Company’s future
plans. Generally, forward-looking information can be identified by
the use of forward-looking terminology such as “plans”, “expects”
or “does not expect”, “is expected”, “budget”, “scheduled”,
“estimates”, “forecasts”, “intends”, “anticipates” or “does not
anticipate”, or “believes”, or variations of such words and phrases
or state that certain actions, events or results “may”, “could”,
“would”, “might” or “will be taken”, “occur” or “be achieved”.
Forward-looking information is subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of Radient, as the
case may be, to be materially different from those expressed or
implied by such forward-looking information. Although Radient has
attempted to identify important factors that could cause actual
results to differ materially from those contained in
forward-looking information, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can
be no assurance that such information will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward-looking information. Radient does
not undertake to update any forward-looking information, except in
accordance with applicable securities laws.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Radient Technologies (TSXV:RTI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Radient Technologies (TSXV:RTI)
Historical Stock Chart
From Dec 2023 to Dec 2024